Prognostic implications of fibroblast growth factor receptor 4 polymorphisms in primary breast cancer.

doi:10.1002/mc.22819

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Prognostic implications of fibroblast growth factor receptor 4 polymorphisms in primary breast cancer.

Molecular carcinogenesis - 1 Aug 2018

Wei Wei, You Zilong, Sun Shanshan, Wang Yuhang, Zhang Xianyu, Pang Da, Jiang Yongdong

Abstract excerpt

Fibroblast growth factor receptor 4 (FGFR4) belongs to the receptor tyrosine kinase (RTK) family, and FGFR4 polymorphisms have been implicated in both normal development and cancer, including breast cancer. In the present study, we investigated correlations between polymorphisms in FGFR4 and breast cancer prognosis. The FGFR4 SNPs rs1966265 and rs351855 were genotyped in 747 breast cancer patients using the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to FGFR4 gene

Share to Genetic Predisposition to Disease

Share to Kaplan-Meier Estimate

Share to Polymorphism, Single Nucleotide

Share to Prognosis

Share to Receptor, Fibroblast Growth Factor, Type 4

Share to Up-Regulation

Source

Open in PubMed

Identifiers

PMID: 29603419
DOI: 10.1002/mc.22819

Genes

FGFR4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic implications of fibroblast growth factor receptor 4 polymorphisms in primary breast cancer.PMID 29603419Read ↗

Association of FGFR3 and FGFR4 gene polymorphisms with breast cancer in Chinese women of Heilongjiang province.Semantic proximity Read ↗

Effects of FGFR1 Gene Polymorphisms on the Risk of Breast Cancer and FGFR1 Protein Expression.Semantic proximity Read ↗

An updated meta-analysis of the association between fibroblast growth factor receptor 4 polymorphisms and susceptibility to cancer.Semantic proximity Read ↗

FGFR4: A promising therapeutic target for breast cancer and other solid tumors.Semantic proximity Read ↗

Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis.Semantic proximity Read ↗

Risk of genome-wide association study newly identified genetic variants for breast cancer in Chinese women of Heilongjiang Province.Semantic proximity Read ↗

Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor.Semantic proximity Read ↗

Variants of FGFR2 and their associations with breast cancer risk: a HUGE systematic review and meta-analysis.Semantic proximity Read ↗

Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women.Semantic proximity Read ↗

Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis.Semantic proximity Read ↗

Challenges and opportunities in the targeting of fibroblast growth factor receptors in breast cancer.Semantic proximity Read ↗

Prognostic Role of the FGFR4-388Arg Variant in Lung Squamous-Cell Carcinoma Patients With Lymph Node Involvement.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.